We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 cases.
- Authors
Leme, Petr; Attarbaschi, Andishe; Bén, Marie C.; Bertrand, Yves; Castoldi, Gianluigi; Forestier, Erik; Garand, Richard; Haas, Oskar A.; Kagialis-Girard, Sandrine; Ludwig, Wolf-Dieter; Matutes, Estella; Mejstříkov, Ester; Pages, Marie-Pierre; Pickl, Winfried; Porwit, Anna; Orfao, Alberto; Schabath, Richard; Star, Jan; Strobl, Herbert; Talmant, Pascaline
- Abstract
Objectives: Patients with near-tetraploid (karyotype: 81 - 103 chromosomes) acute lymphoblastic leukemia (NT-ALL) constitute about 1% of childhood ALL and data reported on them are limited and controversial. The aim of the study was to enlarge the knowledge on these rarely occurring ALL. Methods: The members of the European Group for Immunophenotyping of Leukemias (EGIL) searched retrospectively their databases for NT-ALL patients. Results: We collected data of 36 European children from seven European countries with NT-ALL diagnosed since 1992. All patients reached complete remission (CR) after induction chemotherapy. Their blasts were negative for peroxidase and BCR-ABL1. Ten children were diagnosed as T-cell ALL (T-ALL) EGIL categories (T-I n = 2, T-II n = 2, T-III n = 3, T-IV n = 3) and four displayed various structural chromosomal abnormalities. Eight of 10 T-ALL remained in 1st CR; one died in CR from sepsis and one is alive in 2nd CR. Median survival was 88 (7-213) months. B-cell precursor (BCP) ALL was diagnosed in 26 children. Thirteen were positive for ETV6-RUNX1 and are alive in 1st CR for 32-147 months. Ten children were ETV6-RUNX1 negative and remained in 1st CR for 16-163 months. One girl with hypodiploid and NT metaphases and ETV6-RUNX1-negative BCP-ALL and one of two boys with NT-BCP-ALL not examined for ETV6-RUNX1 died of infection after stem cell transplantation in 2nd/3rd CR. Secondary myelodysplastic syndrome developed in two patients with NT-BCP-ALL. Conclusions: Our data demonstrate immunophenotypic, cytogenetic, and molecular heterogeneity of NT-ALL and favorable prognosis of most NT-ALL across different immunophenotypic and/or genetic ALL subtypes.
- Subjects
EUROPE; LYMPHOBLASTIC leukemia; MOLECULAR genetics; DRUG therapy; IMMUNOPHENOTYPING; STEM cell transplantation
- Publication
European Journal of Haematology, 2010, Vol 85, Issue 4, p300
- ISSN
0902-4441
- Publication type
Article
- DOI
10.1111/j.1600-0609.2010.01493.x